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Abstract
The inside of the cell is a complex environment that is difficult to simulate when studying proteins
and other molecules in vitro. We have developed a device and system that provides a controlled
environment for Nuclear Magnetic Resonance (NMR) experiments involving living cells. Our device
comprises two main parts, an NMR detection region and a circulation system. The flow of medium
from the bottom of the device pushes alginate encapsulated cells into the circulation chamber. In the
chamber, the exchange of oxygen and nutrients occurs between the media and the encapsulated cells.
When the media flow is stopped, the encapsulated cells fall back into the NMR detection region, and
spectra can be acquired. We have utilized the bioreactor to study the expression of the natively
disordered protein α-synuclein, inside Escherichia coli cells.
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1. Introduction
Most biophysical experiments on proteins are conducted in dilute solution. Most proteins,
however, serve their physiologically relevant function in cells, which have a complex crowded
environment that affect several protein properties compared to dilute solution [1;2;3;4]. For
this reason, there is an increasing interest in studying proteins inside living cells. Nuclear
magnetic resonance spectroscopy (NMR) has become a popular tool for experiments on living
cells because it provides atomic-level information about cellular components and is
nondestructive [5].
A disadvantage of NMR spectroscopy is its low sensitivity. Selective isotopic enrichment or
labeling of the targeted species with an NMR active nucleus (e.g., 15N, 13C or 19F) is one way
around this problem. Serber et al. suggest that the minimum concentration of the protein under
study should be at least ~150 μM for 15N enrichment or ~50 μM for 13C side chain enrichment
[6]. Therefore, the target protein must be overexpressed or introduced into the cell by other
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means (e.g., micro injection, cell penetrating peptides [5]). To increase sensitivity further, high
cell densities (109–1011 cells/mL) are used, and the data are time averaged.
Current experimental setups for protein in cell NMR have several drawbacks. First, the lack
of aeration and the high cell density create an anaerobic environment. Second, metabolites and
waste products accumulate. These characteristics can decrease cell viability, limiting the cell
types that can be used, and make it difficult to monitor temporal changes. Overcoming these
challenges requires an NMR compatible device that provides a controlled environment for
living cells.
Devices with these characteristics have been developed [7;8;9]. One type is an in-magnet
bioreactor that enables growth of microorganisms to a high density [10;11]. Another type is a
perfusion system that flows media down through immobilized cells [12;13]. These devices
tend to be complex and difficult to fabricate. Furthermore, they are designed to study
metabolism.
Here, we describe a circulating encapsulated cells (CEC) bioreactor and accessories for in-cell
protein NMR. The instrument comprises parts that are commercially available or easily
fabricated. The expression of the natively disordered human protein α-synuclein in Escherichia
coli is used to demonstrate its capabilities. α-Synuclein is a 14.5 kDa protein implicated in the
pathogenesis of Parkinson’s disease [14]. The expression of the plasmid borne α-synuclein
gene is controlled by a lactose inducible, phage T7 promoter. We investigate the bioreactor’s
ability to measure the accumulation of α-synuclein with time in living E. coli cells.
2. Results
2.1 The CEC bioreactor
The bioreactor is made from Teflon to facilitate NMR experiments involving 1H detection (We
have made a similar version from Plexiglass for 19F detection). We designed the bioreactor for
an 8 mm probe to facilitate fabrication with conventional machine tools. The bioreactor
comprises three main parts; an 8 mm diameter tube, a circulation chamber, and an adjustable
threaded cap (Fig. 1). An inlet for an Upchurch Scientific Super Flangeless Fitting is located
on the upper part of the cap (Fig. 1E). A 1/16″ OD inlet for Upchurch Scientific perfluoro
alkoxy alkane tubing is located at the bottom (Fig. 1A).
Most of the components (Fig. 2) are commercially available. The liquid media is contained in
a 1 L Corning three neck spinner flask with a tubing adaptor on one side arm (Fig. 2A). A
peristaltic MasterFlex pump (Fig. 2B), moves the media at a rate of 45 ml/min from the flask,
through the tubing adaptor, into the PFA tubing (Fig. 2, yellow lines). The tubing runs from
the pump, into the bottom of an 8 mm Varian triple resonance z gradient probe through an
opening created by removing the heater (Fig. 2D). The temperature is controlled with the
spectrometer’s FTS Systems heating apparatus (Model TC-84). PFA tubing between the pump
and the bioreactor is placed in a Fisher Scientific Isotemp water bath to warm the media (Fig.
2C), which flows from the bottom of the bioreactor to the top (Fig. 1, arrows on right side).
The PFA tubing at the top of the bioreactor returns the media, via a pH probe, to the 1 L the
Corning three neck spinner flask. The pH probe, pump and NMR spectrometer are connected
to a laptop computer (Fig. 2, green lines).
The 1H-15N band-selective optimized flip-angle short transient (SOFAST) heteronuclear
multiple quantum coherence (HMQC) [15] pulse program provided in the Varian Biopak suite
of pulse sequences was modified to send voltage outputs to the computer. The perfusion pump
is controlled by one of the spare output lines on the Varian Inova console. The pump is switched
on before the first steady state scan, and remains on during the perfusion delay. It is then then
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switched off during the bead settling delay. After the first steady state scan, the pulse sequence
skips the pump control code. The signals are interpreted by LabView (National Instruments)
software, which controls the pump. The software also records the pH value at 1 min intervals.
Cells are electrostatically encapsulated into 1 mm diameter Ca2+ alginate spheres to keep them
in the bioreactor [16]. The circulation of the encapsulated cells facilitates the delivery of
nutrients and waste removal. The bioreactor (Fig. 1) has two states: pump off, and pump on.
When the pump is off, encapsulated cells settle into the 8 mm diameter tube for data acquisition
(Fig. 1, left panel). When the pump is on, the encapsulates travel from the 8 mm diameter tube
into the wider circulation chamber. The movement of the encapsulates from a narrow to wider
tube results in a reduction in pressure causing the encapsulates to circulate in the chamber (Fig.
1, right panel). The pulsed, upward motion also prevents the encapsulates from clogging the
outlet of the cell chamber. Settling of the encapsulates requires approximately 90 s from the
time the pump is turned off.
2.2 CEC bioreactor without flowing media
To assess the bioreactor’s suitability for in cell NMR experiments, the 1H-15N HSQC spectrum
of encapsulated E. coli in the bioreactor is compared to the HSQC spectrucm of 15N enriched
α-synuclein obtained in a conventional 5 mm NMR probe (Fig. 3A,B). The in vitro spectrum
of purified α-synuclein (Fig. 3C) is shown as a reference. The in vitro spectra were acquired
at a lower temperature because we have shown that the in vitro spectrum acquired at 10 °C is
equivalent to in cell spectra acquired at 37 °C [1; 17]. The similarity of the spectra in Fig. 3
indicates that α-synuclein can be detected in the bioreactor.
To assess the bioreactor’s effect on spectral quality, the in cell HSQC spectrum of encapsulated
E. coli expressing 15N enriched α-synuclein in the bioreactor is compared to the HSQC
spectrum of the same encapsulates in a 5 mm tube (Fig. 3A,D). The spectrum of the
encapsulated cells in the 5 mm tube is consistent with the published spectrum [18]. The
crosspeaks broaden when encapsulates are placed in the bioreactor, but the quality of spectra
is only slightly degraded.
2.3 CEC bioreactor with flowing media
The expression of α-synuclein was monitored with the 1H-15N SOFAST HMQC pulse
sequence, rather than the HSQC sequence, to obtain better time resolution. Spectra as a function
of time are shown in Fig. 4A–C. The spectrum of the encapsulates before induction (Fig. 4A)
has few crosspeaks and no unambiguous α-synuclein crosspeaks. After induction new
crosspeaks begin to appear. With each successive spectrum, the crosspeaks increase in volume
as seen at 4 h and 18 h (Figs. 4B and C). Using methods described by Slade et al. [19] we
determined the intracellular concentration of α-synuclein to be 0.8 mM at 18 h.
As a control, the encapsulates were removed after the experiment and a spectrum was acquired
of the surrounding media (Fig. 4D). The spectrum shows only a weak crosspeak, indicating
that the bulk of the signal comes from the encapsulated cells. The viability of the E. coli in the
bioreactor experiments was determined by plating serial dilutions of dissolved encapsulates
before and after each experiment. The viability was 95%. The pH of the medium perfused
around the encapsulated cells remained at 7.00 for the duration of the experiment.
Although the CEC bioreactor provides an environment where encapsulated E. coli cells express
α-synuclein, our sacrifice of spectral resolution for increased time resolution (see the
Experimental section) made it difficult to distinguish between metabolites and protein
crosspeaks. To determine which crosspeaks corresponded to α-synuclein, we collected spectra
of fresh media (Fig 5A) and of E. coli containing a pUC18 plasmid [20] without the α-synuclein
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gene (Fig 5B). Overlaying these spectra with the spectrum of α-synuclein expressed in the
bioreactor (Fig 5C), shows that most of the crosspeaks are from α-synuclein (Fig 5D).
The overlay allowed us to quantify temporal changes in crosspeak volumes (Fig 6). The
crosspeak from the defined minimal media is the only crosspeak detectable at 30 min (Fig 6H).
Although induction occurred at 30 min, there was a lag phase of approximately 4 h before
crosspeaks could be detected (Fig 6A–B, E–G). Some crosspeaks are not detectable until
approximately 7 h (Fig 6C,D),
The volumes of α-synuclein crosspeaks increased with time, beginning with a lag phase before
growing exponentially to a plateau (Fig 6A–E). One crosspeak deviated from this trend (Fig
6D), most likely because the poor resolution in this area of the spectrum (Fig 5D). Temporal
changes in crosspeak volumes for two metabolites showed different trends. One metabolite
remained constant (Fig 6F), while the other metabolite showed a time dependence that
resembled the α-synuclein crosspeaks (Fig 6G). The crosspeak from the defined minimal
media, is the only crosspeak that showed a slight decrease in intensity with time (Fig 6H).
3. Discussion
The CEC bioreactor (Fig. 1) is designed to provide a controlled environment for NMR
experiments involving living cells. It allows media to deliver nutrients and remove waste from
encapsulated cells contained in a circulation chamber (Fig. 1, right panel). When the flow of
media is stopped, the encapsulated cells settle allowing data acquisition (Fig. 1, left panel).
In the experimental setup, the CEC bioreactor is the only component located inside the
spectrometer (Fig. 2). This configuration allows the external components to be altered without
removing the bioreactor before or during the experiment, facilitating studies requiring different
conditions in one experiment. The setup is also versatile. Different solution probes and sensors
can be inserted between the external components. The tubing can be rerouted, for example, to
send the media to a waste container. In addition, the material used to make the bioreactor can
be changed for experiments requiring different isotopic nuclei detection. Here we use Teflon
for 15N detection, but a Plexiglass bioreactor can be used for 19F NMR.
To our knowledge, the CEC bioreactor is the first bioreactor suitable for protein in cell NMR
experiments (Fig. 3A,B). The design provides an environment where encapsulated cells can
express protein while maintaining reasonably high quality in cell NMR spectra (Fig 3C–D).
Furthermore, the bioreactor can be used to quantify temporal changes in crosspeak volumes
during the experiment (Fig. 4 and 5).
Our data allow us to draw several conclusions. We showed that α-synuclein was present at an
intracellular concentration of 0.8 mM at 18 h. Using information from Figure 6, we conclude
that the detection limit for in-cell NMR is approximately 0.14 mM. This finding is consistent
with other work on the minimal intracellular protein concentration needed for in-cell NMR
[6]. For most residues, the detection limit is achieved after 3 h. Two protein crosspeaks do not
follow this trend in that they are not detectable until approximately 7 h (Fig. 6C,D). The
crosspeaks from glycine residues that comprise the ear shaped pattern in the upper left region
of α-synuclein Figure 4 (15N ppm 108–113, 1H ppm 8.3–8.7), follow a similar trend. The delay
in detectability may be due to differential binding of α-synuclein to other intracellular
components, which broadens their crosspeaks. Another possibility for the delay is differential
relaxation, because in vitro models for α-synuclein dynamics show that certain residues
experience less mobility [17]. Decreased mobility produces broader, weaker signals, which
would explain the longer time required to detect them.
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In summary, the CEC bioreactor provides a controlled environment where protein NMR
spectra data can be acquired in living E. coli cells. Our next goal is to show that the CEC
bioreactor is compatible with other cell types, and is versatile enough for metabolomic, as well
as protein NMR experiments. We specifically want to focus on eukaryotic cells whose viability
is adversly affected by current methods. Our long-term goal is to monitor temporal changes in
protein structure and metabolism due to perturbations, such as drug interactions, in human
cells, and so increase the understanding of intracellular components under physiological
conditions.
4. Experimental
4.1 Purification of wild type α-synuclein for in vitro experiments
The pT7-7 plasmid containing the α-synuclein gene was transformed into E. coli Bl-21 (DE3)
Gold cells (Strategene). Plasmid containing cells were selected with 0.1 mg/mL ampicillin. A
5 mL overnight culture was grown from a single colony and used to inoculate a 50 mL culture
of Spectra 9 15N-enriched media (Cambridge Isotope Laboratories) at 37°C in a rotary shaker
(225 rpm, New Burnswick Scientific, Model I-26). The saturated overnight culture was used
to inoculate 1 L of M9 minimal media [21] containing 1 g/L 15NH4Cl. After reaching an
absorbance at 600 nm (A600) of 0.8–1.0, the culture was induced with isopropyl β-D-
thiogalactopyranoside (IPTG) to a final concentration of 1 mM. The culture was placed in the
rotary shaker (225 rpm) at 37°C.
After 5 h the cultures were pelleted using a swinging bucket centrifuge (Sorvall RC-3B,
H6000A rotor) at 1600g for 30 min at 4°C and the pellet was stored at −20°C. The pellet was
resuspended in 30 mL of lysis buffer (50 mM Tris, 150 mM NaCl, 1 mM
phenylmethanesulfonyl fluoride, 0.4 g/L lysozyme, pH 8.0). RNase and DNase were added to
a final concentration of 0.02 g/L each. The samples were stirred (250 rpm) at 4°C for 20 min.
The lysate was sonicated (Branson Ultrasonics, Fischer Scientific) continuously for 5 min,
boiled in a water bath for 20 min, and then centrifuged at 13,000g for 30 min at 4°C (SS-34
rotor). The supernatant was subjected to streptomycin sulfate precipitation (10 g/L) and
centrifuged for 30 min at 4°C. The supernatant was subjected to (NH4)2SO4 precipitation (361
g/L) and centrifuged again for 30 min at 4°C. The pellet was resuspended in 20 mM sodium
phosphate buffer (pH 7.4) and dialyzed (Thermo Scientific, 3500 MWCO) overnight, with
stirring at 4°C, against the same buffer.
The protein was further purified by anion exchange chromatography (GEHealtcare, Q
Sepharose HiPrep 16/10 column) with a 0–1 M linear gradient of NaCl in 20 mM phosphate
buffer (pH 7.4). Fractions were subjected to SDS-PAGE on an 18% gel with Commassie
blilliant blue staining. Fractions containing α-synuclein were pooled and dialyzed against water
overnight, with stirring, at 4°C. The protein was concentrated in a YM-3 Centricon filter
(Millipore, MWCO 3500) using centrifugation at 1000g (SS-34 rotor) for 1 h at 4°C. The purity
of the protein was determined by SDS-PAGE with Coomassie staining. The pure α-synuclein
was lyophilized (Labconco) and stored at −20°C. The yield was 35–60 mg of pure α-synuclein
per liter of saturated cell culture.
4.2 Cultivation of E. coli for in-cell NMR experiments
A 5 mL overnight culture was grown from a single colony and used to inoculate a 500-mL
Erlenmeyer flask containing 50 mL of isotopically enriched media, as described above. After
the culture reached an A600 of 0.8–1.0, the cells were induced with IPTG to a final concentration
of 1 mM. Expression was allowed to proceed for 4 h. The cells were gently harvested by using
the swinging bucket centrifuge for 30 min at 4°C. The pellet was resuspended in 1 mL of spent
media.
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4.3 Cultivation and encapsulation of E. coli for NMR bioreactor experiments
A 5 mL overnight culture was grown from a single colony as described above and used to
inoculate 150 mL of Luria Broth (10 mg/mL Tryptone, 5 mg/mL yeast extract, 10 mg/mL
NaCl) at 37°C. The culture was grown in the rotary shaker (225 rpm) to an A600 of 0.8–1.0.
The cells were gently harvested in the swinging bucket centrifuge for 20 min at 4°C and
resuspended in 1 mL of spent media. The resuspended cells were mixed with a 2% w/v alginate
(Sigma) solution in 20 mM phosphate, 150 mM NaCl (pH 7.4) to give a final concentration of
1% alginate (50:50 mixture alginate:cell slurry).
The electrostatic encapsulation device (Fig. 7) comprised a 1 mL insulin syringe (BD), a 24
gauge winged anigocatheter (0.7 × 19 mm tip, Braun), a 23 gauge needle (BD), a syringe pump
(Braintree Scientific 8000), and an adjustable high voltage power supply (Spellman SL10).
The insulin syringe, equipped with the needle, was loaded with the cell/alginate mixture. The
other needle, which was inserted horizontally through the center of the angiocatheter, was
connected to the positive pole of the power supply. The negative pole of the power supply was
placed into the 150 mM CaCl2 solution. The syringe containing the mixture was inserted into
the top of the angiocatheter and placed onto the pump. The syringe pump was set to a rate of
0.714 mL/min, the power supply voltage to 3.35 kV, and the stir-plate to approximately 300
rpm. The tip of the angiocatheter was centered 1.2 cm above a 250 mL beaker containing 150
mL of 150 mM CaCl2. The mixture was forced through the tip of the angiocatheter and streamed
into the CaCl2 solution. The Ca2+ polymerizes the alginate which, in turn, forms encapsulated
beads containing the cells. The encapsulated cells were retrieved with suction and placed in a
15 mL Falcon tube containing 150 mM CaCl2 solution for transport to the NMR spectrometer.
The CaCl2 solution was removed and the encapsulated cells were washed with the phosphate-
free minimal medium. The phosphate-free minimal medium consisted of 100 mM HEPES (pH
7.4), 150 mM CaCl2, phosphate-free M9 salts [1mg/mL 15NH4Cl, 2 mM MgCl2, 1 μg/mL
thiamine, 2 % v:v 10x 15N-enriched Bioexpress 1000 media (Cambridge Isotope Laboratories)]
and 0.1 mg/mL ampicillin. After washing, the encapsulated cells were placed inside the
bioreactor, which was then placed into the spectrometer. After acquiring the initial spectrum,
lactose was added to a final concentration of 1% w/v. The lactose acts as an inducer and the
sole carbon source. For each spectrum, the pump circulated medium through the system at a
rate of 45 mL/min for 30 min. Five min were allotted for the encapsulated cells to settle into
the detection region of the bioreactor. As a control the procedure was repeated for E. coli
containing the pUC18 plasmid.
4.4 NMR
Data were acquired at the UNC Biomeolcular NMR facility on a Varian Inova 600 MHz NMR
spectrometer. Data were processed and visualized with NMRpipe and NMRviewJ, respectively
[22;23].
Samples for dilute solution spectra comprised a 90:10 (v:v, pH 7.4) mixture of purified 200
μM α-synuclein solution: D2O in a standard 5 mm NMR tube. 1H-15N HSQC spectra were
acquired at 10°C [1] with a 5 mm Varian Triax triple resonance probe (1H sweep width:
11990.40 Hz; 15N sweep width: 2100 Hz, 8 transients, 128 increments). Each spectrum required
35 min.
Samples for simple in-cell NMR experiments comprised 90:10 (v:v) mixture of resuspended
cells: D2O in a standard 5 mm NMR tube. 1H-15N HSQC [24;25] spectra were acquired as
described above, except with 12 transients and 128 increments. Each spectrum required 1 h.
Samples for encapsulated in-cell NMR experiments comprised encapsulates in a 90:10 (v:v)
mixture of 150 mM CaCl2: D2O in a standard 5 mm NMR tube. For encapsulates in standard
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5 mm NMR tubes, 1H-15N HSQC spectra were acquired as described above. In the
bioreactor, 1H-15N HSQC spectra were acquired unlocked at 37°C with an 8 mm modified
Varian Triax triple resonance z gradient probe as described above. Samples for NMR bioreactor
experiments comprised encapsulated cells in phosphate-free media supplemented with
Bioexpress 1000. 1H-15N SOFAST HMQC spectra were acquired at 37°C as described above,
except with 48 transients and 96 increments. The spectra were acquired unlocked due to the
adverse effects of D2O on cell growth and protein expression. Each spectrum required 35 min.
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The CEC bioreactor. On the left, the pump is off and the encapsulates are settled. On the right,
the pump is on and the encapsulates circulate at a steady state in the upper chamber. A: tubing
inlet, B: NMR detection region, C: circulation chamber, D: adjustable threaded cap, E: fitting
inlet. Orange circles represent encapsulates containing E. coli cells.
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The experimental set-up. A: Corning spinner flask fitted with a vented cap on one side arm
and tubing adaptors on the other, B: peristaltic pump, C: water bath, D: 8 mm probe with heater
removed, E: bioreactor, F: magnet, G: pH probe, H: computer, I: stir plate.
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Comparing α-synuclein spectra. A) In cell HSQC spectrum of alginate encapsulated E. coli
expressing α-synuclein in the bioreactor. B) In cell HSQC spectrum of E. coli expressing α-
synuclein. C) In vitro HSQC spectrum of 200 μM purified wild type α-synuclein in HEPES
buffer, pH 7.2 at 10°C D) In cell HSQC spectrum of alginate encapsulated E. coli expressing
α-synuclein. The spectra shown in panels A, B & D were acquired at 37°C. The spectra in
panels B–D were acquired in a 5 mm NMR tube using a 5 mm probe. The spectrum in panel
A was acquired in the 8 mm bioreactor using an 8 mm probe.
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In-cell SOFAST 15N-1H HMQC [12] spectra (37°C) of E. coli expressing α-synuclein in the
bioreactor. A) Spectrum collected before induction. B) 4 h post induction. C) 18 h post
induction. D) Spectrum of the spent medium.
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Determining which crosspeaks correspond to α-synuclein. A) In-cell SOFAST 15N-1H HMQC
spectrum of the defined phosphate-free minimal media. B) Spectrum of 15N encriched
encapsulated E. coli cells containing the control pUC18 plasmid. C) Spectrum of encapsulated
E. coli expressing α-synuclein. D) Overlay of the spectra [medium (red), puc18 control cells
(cyan), and α-synuclein (black)]. Crosspeaks used in subsequent analysis are labeled a-h.
Spectra were acquired in the 8 mm bioreactor using an 8 mm probe at 37°C.
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Temporal changes in crosspeak volume after inducing α-synuclein expression in the bioreactor.
A–E) α-Synuclein crosspeaks, F–G) Metabolite crosspeaks. H) Crosspeaks from the defined
phosphate free minimal media. Crosspeak volumes are normalized to the largest volume and
are labeled in Figure 5D. Error bars represent the standard error from three independent
experiments.
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Schematic of the electrostatic encapsulation device. A: stir plate, B: beaker containing 150 mM
CaCl2, C: anigocatheter, D: needle, E: insulin syringe, F: alligator clip (connects the positive
power supply terminal to the needle) G: high voltage power supply, H: ground, I: negative end
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